PRIME-Met
Проводит Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology
Страница компанииEffects of Prolonged and Chronic Critical Illness Induced by Brain Injury on Metabolic State: Matched Case-control Study
Постоянная ссылка: https://clinomir.ru/trials/nct/NCT06545825/
Источник: ClinicalTrials.gov (U.S. National Library of Medicine). Что откуда
Простыми словами
Словарь терминов- Исследование завершено, новых участников не набирают.
- Возраст участников: 18–74 лет. Остальные условия — в блоке «Кто может участвовать».
- По плану участвуют 30 чел. во всех странах исследования.
- Центров в реестре: 1 в одном городе. Список — ниже на странице.
- Плановая дата окончания (11.2024) уже прошла.
Пересказ собран автоматически из данных реестра, без оценки пользы и рисков. Подробно о рисках и пользе рассказывает врач центра перед подписанием согласия.
Кто может участвовать
Полный текст критериев (на английском, как в ClinicalTrials.gov) · включение: 5 · невключение: 8
Критерии включения
- Patient's age is between 18 and 74
- Stay in the intensive care unit >5 days from the time of injury
- Presence of brain injury or stroke
- Receiving enteral nutrition
- Informed voluntary consent of the patient to participate in the study, or a decision of the medical council to include the patient in the study
Критерии невключения
- Diabetes mellitus
- Acute kidney injury
- Acute liver failure
- Shock of any etiology
- Presence of a cardiac implantable electronic device or neurostimulator
- Presence of a tracheoesophageal fistula
- Positive end expiratory pressure > 12 mbar
- Patients previously included in this trial
Источник: ClinicalTrials.gov, NCT06545825 · запись обновлена в реестре 29 ноября 2024.
Дизайн и результаты
Что измеряют — первичные конечные точки (1), вторичных — 8
- Change from baseline in serum level of total protein — From day 1 to day 20
Цель исследования
Brain injuries, including acute stroke (AS) and traumatic brain injury (TBI), are prevalent pathologies with severe consequences. Cerebral infarction accounts for 65-85% of AS cases, while hemorrhagic stroke, though less common, has a higher mortality rate (30-50%) and limited recovery (10-20%). TBI is a significant medical and socioeconomic issue due to its high prevalence, severe consequences, and the high rates of temporary and permanent disability, particularly among young and working-age adults. The average mortality rate for severe TBI is 39%, with 60% facing unfavorable outcomes according to the Glasgow Outcome Scale.
High levels of permanent disability, a low percentage of patients returning to work, and long-term rehabilitation after brain injury impose a heavy economic and social burden. Severe brain damage often leads to chronic critical illness (CCI), a term introduced in 1985 to describe patients with prolonged ICU stays. CCI affects 6-10% of ICU patients, with an increasing prevalence. About 5-10% of those requiring mechanical ventilation develop CCI, with a significant number following sepsis. The prevalence of CCI is estimated at 34.4 to 42.0 cases per 100,000 people, increasing with age.
Malnutrition and the hypermetabolism-hypercatabolism syndrome are major complications in AS and TBI, leading to poor treatment outcomes and extended recovery periods. Effective rehabilitation is impossible without adequate nutritional support. Despite the universal metabolic response to different types of damage, specific metabolic disorders vary among different pathological conditions, both in macro- and micronutrient exchange.
Developing specialized enteral nutrition products tailored to specific conditions, like brain injury, is of great scientific and practical interest. To advance this development, comprehensive data on metabolic disorders in these patients is essential.
Где проходит
1 центр в 1 городеОткуда эта информация
-
ClinicalTrials.gov (U.S. National Library of Medicine) · NCT06545825 Официальный реестр (США) · загружено 9 ноября 2026Номер протокола, название, цель, статус, сроки, число участников, спонсор, центры
Сведения сведены и нормализованы порталом «Клиномир»: названия компаний и центров приведены к одному написанию. Нашли ошибку? Напишите нам — исправим.